Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized Placebo-controlled Clinical Trial of the Safety and Efficacy of Intravenous Clarithromycin as Immunomodulatory Therapy for the Management of Sepsis

NCT01223690 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT01223690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01223690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized Placebo-controlled Clinical Trial of the Safety and Efficacy of Intravenous Clarithromycin as Immunomodulatory Therapy for the Management of Sepsis
Lead sponsor
University of Athens
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2011
Enrollment
600 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock, severe sepsis